Covaxin Gets Shelf Life Extension Of Up To 12 Months

The approval of extension of shelf life to Covaxin was based on the "additional stability data", it said.

Bharat Biotech's COVID-19 vaccine Covaxin has been granted an extension of shelf life for up to 12 months from the date of manufacture, the company said in a statement. The approval of extension of shelf life by the Central Drugs Standard Control Organisation (CDSCO) was based on the "additional stability data", it said.

Covaxin initially had a shelf life of six months when it first received emergency use approval in the country.

"This approval is based on the availability of additional stability data, which was submitted to CDSCO. The shelf life extension has been communicated to our stakeholders," the company said.

Shelf life is the length of time for which an item remains fit for use.